Then analyzing the options chain and the chart patterns of ABBV AbbVie prior to the earnings report this week, I would consider purchasing the 160usd strike price Calls with an expiration date of 2024-3-15, for a premium of approximately $7.55. If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
Trade closed: target reached
ABBV traded at 172.85 after earnings, and the calls went up from $7.55 (when I wrote this article) to $10.80 at the close on friday (a lot higher intraday), for about 40% gain!
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.